Collaboration with international partners

3 March 2023
Dr James Rooney, Vice President Medical Affairs, Gilead Sciences with Prof Salim Abdool Karim at CAPRISA’s headquarters

In February, CAPRISA hosted delegates from Gilead Sciences in the US and the Institute of Human Virology (IHV) Nigeria aimed at exploring potential collaboration opportunities in the future and establishing research collaborations.  Dr James Rooney, Vice President of Medical Affairs, Gilead Sciences, met with Professor Salim Abdool Karim and senior scientists during his visit on 1 February to gain insights into CAPRISA’s current research.

Dr Evaezi Okpokoro, from IHVN has been the project director for the CAPRISA 094 TRiAD study in Nigeria since 2020. He was hosted by Prof Kogie Naidoo CAPRISA's Deputy Director and the TRiAD study Principal Investigator as well as other CAPRISA TRiAD team members. Nigeria has enrolled over 100 participants in the study, making it the top study recruiting site. Okpokoro expressed an interest in further research collaborations and joint projects. 

Project director for the TRiAD study in Nigeria, meets with CAPRISA's Deputy Director and National PI of TRiAD and CAPRISA TRiAD team. Photo (L-R): Ms Resha Boodhram, Study Co-ordinator; Dr Letitia Shunmugam, Postdoc Research Fellow; Dr Evaezi Okpokoro, Project Director for the TRiAD study in Nigeria; Prof Kogie Naidoo, TRiAD National Lead Investigator for the TRiAD study; Mrs Natasha Samsunder, Director Laboratories and Mr Khodani Ramakulukusha, Data Manager.